brain parenchyma (腦實質)
brain parenchyma (腦實質) 是一種 薄壁組織。
##
##
PlaceholderB
##
##
![]() |
|
![]() |
|
|
![]() |
![]() |
![]() |
![]() |
|
|
|
|
|
湯偉晉 (WeiJin Tang) 編寫的字典 (電子郵件: WeiJin.Tang@gmail.com)(行動電話_湯偉晉_0958-227-243_as_of_2011-01-09_) English-Chinese Online Dictionary,英文-中文 線上字典(詞典),中英字典,英中字典,中英文字典, English Dictionary by WeiJin Tang (湯偉晉 編寫的英文字典)
brain parenchyma (腦實質)
brain parenchyma (腦實質) 是一種 薄壁組織。
資訊來源:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6836164/
##
重點
skeletal muscle represents the largest pool of GSH (5 mM) in the human body since muscle accounts for about 40% of body mass
##
Vancomycin (萬古黴素)
開始_電腦翻譯的中文
Vancomycin: a bacterial antibiotic used against resistant strains of streptococcus and staphylococcus.
萬古黴素:一種用於對抗鏈球菌和葡萄球菌抗藥性菌株的細菌抗生素。
結束_電腦翻譯的中文
numbness (麻木)
numbness (麻木,麻麻的沒有感覺)
median nerve (正中神經) 湯偉晉編寫的英文字典
area of pain and numbness (疼痛和麻木的部位) 湯偉晉編寫的英文字典
Oxidative Stress in the Protection and Injury of the Lacrimal Gland and the Ocular Surface: are There Perspectives for Therapeutics PY2022 IR95 Glutathione 教材
資訊來源:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8963457/
##
lacrimal functional unit (LFU)
The LFU is defined as a system that integrates the ocular surface, the central nervous system (CNS) and the exocrine glands responsible for the tear film. The ocular surface is composed of the cornea, the conjunctiva, and the lids that send sensorial neural inputs to the CNS, and throughout the autonomic nervous system, they provide feedback with stimuli to the exocrine glands, modulating the volume and content of the tear film that wets and nourishes the ocular surface. Among these exocrine glands are the lacrimal gland (LG), Meibomian glands (MG), accessory glands and the epithelial layer of the ocular surface, with their constitutive and regulated secretory and paracrine capacity (Bron and Seal 1986; Halliwell and Gutteridge 1990; Crouch et al., 1991; Droge 2002; Stern et al., 2004; Rocha et al., 2008).
OS is ubiquitous and has been implicated in the protective and pathogenic mechanisms of dry eye (DE) and ocular surface diseases. Therefore, any proposal of therapeutic modulation of those reactions must consider its dual effect (Morrison and Allen 1966; Fridovich 2013; Forman 2016).
As a protector, OS works against microorganisms and other sources of free radicals, maintaining homeostasis and triggering the response to protect against other harmful events that challenge the LFU. In a recent study on tear proteomics, the comparison between healthy and DE individuals revealed that lactoperoxidase (LPO) is the most downregulated enzyme in the DE group (Soria et al., 2017). In parallel, the increase in various proinflammatory proteins in their tears was confirmed in previous studies that used LPO as a biomarker of dysfunction for DE and LFU, as detailed below (Bromberg et al., 1989; Soria et al., 2017).
Throughout evolution, heme peroxidases, similar to myeloperoxidase (MPO), LPO, salivary peroxidase (SPO), and thyroid peroxidase (TPO), were found to be key enzymes for modulating the OS process in the cytoplasmic and secretory fluids (Davies et al., 2008). Antioxidants or free radical scavengers are incorporated into the innate immune arsenal, hormone synthesis and exocrine secretions, generating ROS with antimicrobial actions and counterbalancing the actions of other OS-related enzymes, including the glutathione peroxidases (GPx) family (Morrison and Allen 1966; Petrides and Nauseef 2000; Ihalin et al., 2006; Davies et al., 2008). Recently, a family of six protein isoforms called peroxiredoxins was described, and their structure and function associated with OS were further detailed (Rhee et al., 2012).
As a disease mediator, GPx levels and ROS accumulation have been identified as biomarkers and implicated in the protective mechanisms and damage triggered by the LFU (Wakamatsu et al., 2008). The expression and activity of these markers were associated with DE caused by hormone deficits, systemic autoimmune diseases, microelement deficiency, pollution, and ocular surface disease not necessarily related to systemic conditions (Bakker et al., 2005; Davies et al., 2008; Wakamatsu et al., 2008; Kawashima et al., 2010; Kojima et al., 2012; Uchino et al., 2012; Cejkova and Cejka 2015; Jung et al., 2018).
Recently, a family of six protein isoforms called peroxiredoxins was described, and their structure and function associated with OS were further detailed (Rhee et al., 2012).
As a disease mediator, GPx levels and ROS accumulation have been identified as biomarkers and implicated in the protective mechanisms and damage triggered by the LFU (Wakamatsu et al., 2008).
資訊來源:
Oxidative Stress in the Protection and Injury of the Lacrimal Gland and the Ocular Surface: are There Perspectives for Therapeutics PY2022 IR95 Glutathione 教材
##
中文版的 美國的憲法,公布在 美國在台協會 的官方網站 2025-0404
資訊來源:
https://web-archive-2017.ait.org.tw/zhtw/PUBS/Constitution/constitution.htm
##